"El Instituto Oftalmológico Gómez-Ulla, fundado en Santiago de Compostela por el Dr. Francisco Gómez-Ulla de Irazazábal, es la clínica de oftalmología de referencia en Galicia. Tenemos la misión de cuidar la visión de nuestros pacientes, proporcionándoles la máxima atención personal y profesional. Para ello aplicamos las técnicas más modernas y estamos siempre abiertos a los últimos avances que se producen en oftalmología."

During the past decade, Instituto Oftalmológico Gómez-Ulla conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Oftalmológico Gómez-Ulla" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "IVERIC bio, Inc." with 1 trials sponsored and "Oxurion" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Instituto Oftalmológico Gómez-Ulla" are "Geographic Atrophy" (4 trials), "Diabetic Macular Edema" (3 trials), "Diabetes Mellitus" (1 trials), "Diabetic Retinopathy" (1 trials) and "Geographic Atrophy Secondary to Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Instituto Oftalmológico Gómez-Ulla" in a lesser frequency.

Most popular intervention types in "Instituto Oftalmológico Gómez-Ulla" are "Drug" (11 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "APL-2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Oftalmológico Gómez-Ulla" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Oftalmológico Gómez-Ulla". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto Oftalmológico Gómez-Ulla, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Oftalmológico Gómez-Ulla, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".